Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tennessee Oncology provides comprehensive community-based cancer care across Tennessee and neighboring regions. It operates one of the largest physician-owned practices nationally with over 75 physicians at more than 30 locations. The group offers full-spectrum oncology services—including chemotherapy, radiation therapy, molecular diagnostics/profiling—and runs one of the leading U.S. clinical trial networks for new cancer therapies. In recent years it has expanded its infrastructure with significant investments such as a $120 million flagship center opening in Nashville by summer 2025. It was also instrumental as a founding partner of OneOncology—a national network consolidating independent community oncology practices to improve access to cutting-edge treatments and research participation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tennessee Oncology.